Status:
NOT_YET_RECRUITING
Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
Medical College of Wisconsin
Conditions:
Stroke
Aphasia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphas...
Detailed Description
This study aims to improve reading rehabilitation for individuals with aphasia, a language disorder that affects many stroke survivors. The goal is to determine whether adding transcranial direct curr...
Eligibility Criteria
Inclusion
- Chronic (\>6 months) left-hemisphere stroke
- Aphasia diagnosis.
- Deficits in reading aloud.
Exclusion
- Eye condition not correctable with lenses and interfering with reading (e.g., blindness)
- Severe apraxia of speech or cognitive deficits preventing participation.
- Participation in one-on-one aphasia rehabilitation during the study period.
- Brain disorders other than stroke (such as Alzheimer's Disease or Dementia, Parkinson's Disease, etc)
- Contraindications of tDCS or MRI
- Skin condition affecting the scull (e.g., psoriasis) or open wounds at the stimulation site.
- Presence of metallic implants (e.g., cardiac stimulators or pacemakers, cochlear implants)
- History of ongoing/unmanaged seizers
- Pregnancy
- Claustrophobia
- Inability to lie flat on the back
Key Trial Info
Start Date :
May 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 14 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06891638
Start Date
May 1 2025
End Date
February 14 2026
Last Update
March 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kessler Foundation
West Orange, New Jersey, United States, 07052
2
Medical College of Wisconsin
Milwaukee, Wisconsin, United States, 53226